Imagine a world where we conquer cancer and genetic diseases. At NTrans Technologies, we solve key challenges in cell and gene therapy: Delivering life-changing therapies to the right cells and tissues.
We leverage nature’s own mechanisms for cellular uptake to ensure efficient and safe therapeutic delivery. Welcome to the next frontier of medicine.
Our proprietary platform is GMP-ready and sets a new standard in cell and gene therapy. We use a non-viral delivery system to harness macropinocytosis - a natural cellular uptake process - for precise and secure delivery of gene-editing technologies.
The mission of NTrans Technologies is to become the leading non-viral delivery platform in cell and gene therapy.
Please contact us at: info@ntranstechnologies.com
Company Details
- Employees
- 7
- Founded
- -
- Address
- J.h. Oortweg 19, Biopartner 1,netherlands
- Phone
- +31 (0)644448450
- in****@****ies.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- ntranstechnologies.com
- HQ
- Leiden, South Holland
Ntrans Technologies Bv Questions
Ntrans Technologies Bv's helpline number is +31 (0)644448450
Ntrans Technologies Bv's website is ntranstechnologies.com
Ntrans Technologies Bv's LinkedIn profile is https://nl.linkedin.com/company/ntrans-technologies
Ntrans Technologies Bv has
7 employees.
View email and phone details for 7
employees at Ntrans Technologies Bv.
Ntrans Technologies Bv's industry is
Biotechnology Research
Ntrans Technologies Bv's top competitors are
Glycostem Therapeutics,
Vectory,
Predica Diagnostics Bv,
Pan Cancer T,
Meatable,
Divvly,
Leiden University Medical Center,
Necstgen,
Proqr Therapeutics,
The Cgt Circle.
Ntrans Technologies Bv's support email address is info@ntranstechnologies.com
Ntrans Technologies Bv's categories are Biotechnology Research
Ntrans Technologies Bv's founding year is 2015
